ArticleJournal of pediatric surgery2026
Development of a novel tubular scaffold for tissue-engineered small intestine.
Article in Journal of pediatric surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeInfants with short bowel syndrome (SBS) have significant morbidity and mortality, especially if they depend on parenteral nutrition. Tissue-engineered small intestine (TESI) has been considered a potential therapeutic option for SBS but normal peristaltic function remains a challenge. The purpose of this study was to develop a novel tubular scaffold that promotes smooth muscle cell (SMC) alignment and ultimately peristalsis of TESI constructs.
methodsTubular scaffolds with aligned fibers were fabricated by electrospinning a 1:1 blend of polycaprolactone/type I collagen onto a mandrel rotating at 9,000-11,000 rpms. The fiber diameter, alignment, mechanical properties, and in vitro degradation rate were characterized. Primary human intestinal SMCs were seeded on aligned fiber tubular scaffolds and non-aligned scaffolds, cultured for 1 week, and analyzed with confocal and scanning electron microscopy to assess SMC alignment. Non-aligned scaffolds were fabricated with identical parameters of aligned fiber scaffolds except the mandrel speed was 1,000 rpms.
resultsScaffolds spun at 9-11,000 rpms (aligned) had circumferentially aligned fibers compared to those spun at 1,000 rpms (non-aligned). The aligned scaffolds demonstrated anisotropic mechanical properties with higher stiffness and strength when tensile tested in the direction of the fibers compared to perpendicular to the fibers. SMCs seeded on scaffolds demonstrated good alignment on aligned compared to non-aligned scaffolds which demonstrated more random orientation.
conclusionsWe developed electrospun tubular scaffolds with circumferentially aligned fibers that promote SMC alignment, have good mechanical strength and degradation profile suitable for the development of TESI. Future work will evaluate in vivo degradation and tissue formation of seeded constructs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.